Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $4.0B |
| Sales growthchange from the year before | +4.0% |
| Gross marginshare of sales left after the direct cost of what it sells | 59.4% |
| Net marginshare of sales kept as profit | 21.6% |
| Free-cash-flow marginspare cash generated per $100 of sales | 21.1% |
| Return on equityprofit vs. shareholders' accounting value | n/m |
| Debt / equitydebt vs. shareholders' accounting value | n/m |
| Change in share countnegative = the company is buying back its shares | -3.0% |
3 insiders sold $4.1M on the open market.
| Vadala ShawnChief Financial Officer | SoldAug 3 | 2,240 shat $1432.00 · $3.2M |
| Keller GerryHead of Process Analytics | SoldAug 3 | 240 shat $1427.14 · $343K |
| Salice Thomas PDirector | SoldAug 3 | 415 shat $1444.62 · $600K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy